Quick Answer
cbdMD, Inc. reported Total Revenue of $19.19 million for the year ending 2025.
- cbdMD, Inc. showed a decrease of -1.5% in Total Revenue from 2024 to 2025.
- This data is from cbdMD, Inc.'s annual report (Form 10-K), filed with the SEC on December 19, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: $199.8 thousand | Q1 2017: $1.41 million | Q2 2017: $1.79 million | Q4 2017: $687.8 thousand | Q1 2018: $3.08 million | Q2 2018: $3.20 million | Q4 2018: $465.7 thousand | Q1 2019: $5.64 million | Q2 2019: $8.01 million | Q4 2019: $10.15 million | Q1 2020: $9.40 million | Q2 2020: $10.64 million | Q4 2020: $12.33 million | Q1 2021: $11.80 million | Q2 2021: $10.56 million | Q4 2021: $9.32 million | Q1 2022: $9.63 million | Q2 2022: $8.59 million | Q4 2022: $6.09 million | Q1 2023: $6.24 million | Q2 2023: $6.12 million | Q4 2023: $5.38 million | Q1 2024: $4.38 million | Q2 2024: $5.17 million | Q4 2024: $5.11 million | Q1 2025: $4.75 million | Q2 2025: $4.61 million | Q4 2025: $5.02 million.
- Over the full 10 years of available data (2016 to 2025), cbdMD, Inc.'s Total Revenue has grown by 844.6%.
- Historical annual values: Fiscal year 2025: $19.19 million | Fiscal year 2024: $19.48 million | Fiscal year 2023: $24.16 million | Fiscal year 2022: $35.40 million | Fiscal year 2021: $44.48 million | Fiscal year 2020: $41.88 million | Fiscal year 2019: $23.65 million | Fiscal year 2018: $459.1 thousand | Fiscal year 2017: $4.47 million | Fiscal year 2016: $2.03 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: